+ Follow EVERYDAY CARE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 83639
[Title] => New osteoarthritis clinical trial okays anti-inflammatory drug
[Summary] => PRAGUE – In a unique managed care clinical trial, Mobic (meloxicam), designed to relieve the signs and symptoms of osteoarthritis, showed significantly greater "patient success" than other commonly used prescription nonsteroid anti-inflammatory drugs (NSAIDs).
The randomized study, which compared Mobic to "usual care," or whatever prescription-NSAID patients’ individual physicians selected as their osteoarthritis treatment, was presented for the first time at the Annual European Congress of Rheumatology in this city.
[DatePublished] => 2001-07-09 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
EVERYDAY CARE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 83639
[Title] => New osteoarthritis clinical trial okays anti-inflammatory drug
[Summary] => PRAGUE – In a unique managed care clinical trial, Mobic (meloxicam), designed to relieve the signs and symptoms of osteoarthritis, showed significantly greater "patient success" than other commonly used prescription nonsteroid anti-inflammatory drugs (NSAIDs).
The randomized study, which compared Mobic to "usual care," or whatever prescription-NSAID patients’ individual physicians selected as their osteoarthritis treatment, was presented for the first time at the Annual European Congress of Rheumatology in this city.
[DatePublished] => 2001-07-09 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
